Twist Bioscience (TWST) Total Debt (2018 - 2026)

Twist Bioscience has disclosed Total Debt across 7 years of filings, most recently posting $15.0 million for Q1 2026.

• In Q1 2026, Total Debt changed 0.0% year-over-year to $15.0 million; the TTM figure through Mar 2026 stood at $15.0 million (changed 0.0% YoY), while the FY2025 annual figure was $15.0 million, changed N/A from the prior year.
• Total Debt held at $15.0 million in Q1 2026, from $15.0 million in the prior quarter.
• Over the last five years, Total Debt for TWST reached as high as $15.0 million in Q4 2024 and fell as low as $15.0 million in Q4 2024.
• The 3-year median for Total Debt is $15.0 million (2024), against an average of $15.0 million.
• The widest YoY moves for Total Debt: up 0.0% in 2025, down 0.0% in 2025.
• A 3-year view of Total Debt shows it stood at $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025, then changed by 0.0% to $15.0 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $15.0 million, $15.0 million, and $15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.